IRIS
MAZZINI, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.819
NA - Nord America 3.830
AS - Asia 3.411
SA - Sud America 502
AF - Africa 190
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 12.763
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.682
RU - Federazione Russa 1.329
SG - Singapore 1.224
IE - Irlanda 855
IT - Italia 757
CN - Cina 714
DE - Germania 491
HK - Hong Kong 450
VN - Vietnam 426
BR - Brasile 381
SE - Svezia 369
FR - Francia 225
UA - Ucraina 216
FI - Finlandia 137
BD - Bangladesh 136
GB - Regno Unito 127
BJ - Benin 101
IN - India 96
KR - Corea 94
CA - Canada 76
JP - Giappone 48
PL - Polonia 48
NL - Olanda 46
AR - Argentina 43
AT - Austria 41
MX - Messico 41
ID - Indonesia 38
ZA - Sudafrica 38
TR - Turchia 36
CZ - Repubblica Ceca 29
IQ - Iraq 28
IR - Iran 27
ES - Italia 25
BE - Belgio 24
EE - Estonia 24
LT - Lituania 17
EC - Ecuador 16
DK - Danimarca 15
CL - Cile 14
CO - Colombia 13
JO - Giordania 13
DZ - Algeria 12
PY - Paraguay 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
JM - Giamaica 9
DO - Repubblica Dominicana 8
MA - Marocco 8
PK - Pakistan 8
TN - Tunisia 8
CH - Svizzera 7
PE - Perù 7
PH - Filippine 7
TH - Thailandia 7
VE - Venezuela 7
UZ - Uzbekistan 6
GR - Grecia 5
KE - Kenya 5
MY - Malesia 5
SA - Arabia Saudita 5
AU - Australia 4
AZ - Azerbaigian 4
BO - Bolivia 4
LV - Lettonia 4
NP - Nepal 4
PA - Panama 4
UY - Uruguay 4
EG - Egitto 3
EU - Europa 3
PS - Palestinian Territory 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GD - Grenada 2
GT - Guatemala 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NG - Nigeria 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CM - Camerun 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
Totale 12.748
Salva come PNG Salva come JPEG
Città #
Dublin 851
Hong Kong 445
Singapore 424
San Jose 422
Jacksonville 351
Ashburn 310
Beijing 262
Moscow 160
Los Angeles 159
Dearborn 157
Council Bluffs 137
Ho Chi Minh City 137
Lauterbourg 129
Chandler 122
Cotonou 101
Seoul 91
Buffalo 80
Hanoi 78
Novara 77
Munich 76
New York 73
Lawrence 72
Princeton 72
Wilmington 70
Dallas 64
Piemonte 61
Rome 53
Turin 53
Milan 51
Orem 51
San Mateo 50
Santa Clara 50
Ann Arbor 49
Bremen 48
São Paulo 45
Helsinki 43
Boardman 36
Frankfurt am Main 35
Houston 34
Mülheim 34
Warsaw 33
Tokyo 32
Falkenstein 31
Nuremberg 29
Denver 25
Brno 24
Stockholm 24
Strasbourg 24
Toronto 24
Brooklyn 23
Chennai 23
Johannesburg 23
Montreal 23
Redondo Beach 23
The Dalles 23
Vienna 21
Mexico City 20
Amsterdam 19
London 19
Phoenix 19
Atlanta 18
Brussels 18
Chicago 18
Tianjin 18
Andover 17
Nanjing 17
Columbus 16
Jakarta 15
Rio de Janeiro 15
Vercelli 15
Ankara 14
Da Nang 14
Guangzhou 14
Haiphong 14
Hải Dương 14
Manchester 14
Monmouth Junction 14
Seattle 14
Turku 14
Woodbridge 14
Hangzhou 13
Poplar 13
Zanjan 13
Amman 12
Boston 12
Hillsboro 12
Kunming 11
San Francisco 11
Tornaco 11
Baghdad 10
Biên Hòa 10
Quận Bình Thạnh 10
Villadossola 10
Kocmyrzów 9
Ottawa 9
St Louis 9
Curitiba 8
Dhaka 8
Hefei 8
Kocaeli 8
Totale 6.609
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 246
Retrospective observational study on the use of acetyl-L-carnitine in ALS 189
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 178
Advances in stem cell therapy for amyotrophic lateral sclerosis 174
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 161
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 158
Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine: A Population-Based Study. 154
Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis 141
The First Case of the TARDBP p.G294V Mutation in a Homozygous State: Is a Single Pathogenic Allele Sufficient to Cause ALS? 141
Human neural stem cell transplantation in ALS: initial results from a phase I trial. 137
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 133
Coeliac disease mimicking Amyotrophic Lateral Sclerosis. 131
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 130
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study 128
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 128
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways 124
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 122
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 122
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 121
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 120
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 119
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 117
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 116
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 116
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis 115
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 113
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 113
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis 112
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 112
Extensive genetics of ALS: a population-based study in Italy. 111
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 111
The multistep hypothesis of ALS revisited: The role of genetic mutations 111
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 110
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 109
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 109
A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient 107
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 107
null 105
Cognitive impairment across ALS clinical stages in a population-based cohort 104
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 103
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations 101
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 100
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 99
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 98
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 98
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 97
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 96
Autologous Stem Cells Transplantation in Amyotrophic Lateral Sclerosis: A Phase I Clinical Trial 96
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 95
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 94
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 94
Transplantation of mesenchymal stem cells in ALS. 94
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 94
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 94
A rare case of conjugal amyotrophic lateral sclerosis. 94
Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. 94
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 94
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 92
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 91
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. 90
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 90
ATXN-2 CAG repeat expansions are interrupted in ALS patients 89
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 89
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 88
Authors' response to a letter from Dr. Esquinas. 87
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 86
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 85
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 84
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 83
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 82
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 81
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 81
SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS) 81
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 80
C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. 80
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 79
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis 79
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 78
Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's disease 78
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. 78
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis 78
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 77
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population 77
Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population 77
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis 77
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 77
Long-term survival of participants in a phase II randomized trial of RNS60 in amyotrophic lateral sclerosis 76
VPS54 genetic analysis in ALS Italian cohort 75
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis 74
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 74
Non-invasive ventilation after surgery in amyotrophic lateral sclerosis 74
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 74
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 72
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 72
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 72
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 71
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 71
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementia 71
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study 71
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 71
Totale 10.202
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022594 33 10 57 70 27 10 19 14 46 18 152 138
2022/20231.702 87 84 61 25 112 121 53 81 927 21 92 38
2023/2024644 59 41 78 33 101 20 94 9 11 7 60 131
2024/20252.099 45 44 122 44 39 235 136 212 405 207 171 439
2025/20266.453 327 255 392 844 700 462 841 1.010 419 490 452 261
Totale 13.020